TIDMCRW

RNS Number : 1606W

Craneware plc

14 April 2023

14 April 2023

Craneware plc

("Craneware" or the "Company" or the "Group")

Block Listing Announcement

Schedule 6 , Block Admission Period to 14 April 2023

This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month period under the Company's block listing for employee share plans.

 
 Name of the company                 Craneware plc (the "Company") 
 
 Names of the schemes                Approved Share Option Plan 
                                      2007 
 
                                      Schedule 4 Company Share Option 
                                      Plan 2016 
 
                                      Unapproved Company Share Option 
                                      Plan 2016 
 
                                      Long Term Incentive Plan 2016 
 
                                      SAYE Option Plan 2018 
 
                                      Employee Stock Purchase Plan 
                                      2018 
                                    --------------------------------- 
 
 Period of return:                   15/10/2022 to 14/04/2023 
                                    --------------------------------- 
 
 Balance of unallotted securities    Approved Share Option Plan 
  under scheme(s) from previous       2007: 
  return:                             342,301 ordinary shares of 
                                      1p each in the capital of 
                                      the Company ("Ordinary Shares") 
 
                                      Schedule 4 Company Share Option 
                                      Plan 2016: 50,000 Ordinary 
                                      Shares 
 
                                      Unapproved Company Share Option 
                                      Plan 2016: 200,000 Ordinary 
                                      Shares 
 
                                      Long Term Incentive Plan 2016: 
                                      100,000 Ordinary Shares 
 
                                      SAYE Option Plan 2018: 100,000 
                                      Ordinary Shares 
 
                                      Employee Stock Purchase Plan 
                                      2018: 84,370 Ordinary Shares 
                                    --------------------------------- 
 
 Plus: The amount by which           None 
  the block scheme(s) has been 
  increased since the date of 
  the last return (if any increase 
  has been applied for): 
                                    --------------------------------- 
 
 Less: Number of securities          None 
  issued/allotted under scheme(s) 
  during period: 
                                    --------------------------------- 
 
 Equals: Balance under scheme(s)     Approved Share Option Plan 
  not yet issued/allotted at          2007: 
  end of period:                      342,301 Ordinary Shares 
 
                                      Schedule 4 Company Share Option 
                                      Plan 2016: 50,000 Ordinary 
                                      Shares 
 
                                      Unapproved Company Share Option 
                                      Plan 2016: 200,000 Ordinary 
                                      Shares 
 
                                      Long Term Incentive Plan 2016: 
                                      100,000 Ordinary Shares 
 
                                      SAYE Option Plan 2018: 100,000 
                                      Ordinary Shares 
 
                                      Employee Stock Purchase Plan 
                                      2018: 84,370 Ordinary Shares 
                                    --------------------------------- 
 
 Number and class of securities      24,929,950 Ordinary Shares 
  originally admitted at the          on 13 September 2007 
  date of admission: 
                                    --------------------------------- 
 
 Contact name and telephone          Craig Preston +44 (0) 131 
  number:                             550 3100 
                                    --------------------------------- 
 

Enquiries:

 
                                                    +44 (0)131 550 
 Craneware plc                                       3100 
 Keith Neilson, CEO 
 Craig Preston, CFO 
 
 
                                                    +44 (0)20 3405 
 Alma (Financial PR)                                 0205 
 Caroline Forde, Joe Pederzolli, Kinvara            craneware@almapr.co.uk 
  Verdon 
 
                                                    +44 (0)20 7418 
 Peel Hunt (NOMAD and Joint Broker)                  8900 
 Dan Webster, Andrew Clark, Lait Bose 
 
                                                    +44 (0)20 7597 
 Investec Bank PLC (Joint Broker)                    5970 
 Patrick Robb, Henry Reast, Sebastian Lawrence 
 
                                                    +44 (0)20 3207 
 Berenberg (Joint Broker )                           7800 
 Mark Whitmore, Richard Andrews, Dan Gee-Summons 
 

About Craneware

We at The Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organisations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for US healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualise operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

Together, approximately 40% of registered US hospitals are now our customers, including more than 12,000 US hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 165 million unique patients encounters.

   Learn more at    www.thecranewaregroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRIJMJTMTMBBTJ

(END) Dow Jones Newswires

April 14, 2023 02:00 ET (06:00 GMT)

Craneware (AQSE:CRW.GB)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Craneware.
Craneware (AQSE:CRW.GB)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Craneware.